

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.90646651 |
| 2 | tricarboxylic acid cycle (GO:0006099) | 5.89792095 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.33669178 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.33669178 |
| 5 | NADH metabolic process (GO:0006734) | 5.21847631 |
| 6 | * glycolytic process (GO:0006096) | 5.02490757 |
| 7 | oxaloacetate metabolic process (GO:0006107) | 4.84323990 |
| 8 | proteasome assembly (GO:0043248) | 4.74906853 |
| 9 | regulation of cofactor metabolic process (GO:0051193) | 4.71479653 |
| 10 | regulation of coenzyme metabolic process (GO:0051196) | 4.71479653 |
| 11 | establishment of integrated proviral latency (GO:0075713) | 4.65121367 |
| 12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.59286744 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.46413804 |
| 14 | * gluconeogenesis (GO:0006094) | 4.37427601 |
| 15 | cullin deneddylation (GO:0010388) | 4.31505217 |
| 16 | oxidative phosphorylation (GO:0006119) | 4.27864725 |
| 17 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.27537400 |
| 18 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.23970874 |
| 19 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.21179541 |
| 20 | synaptic vesicle exocytosis (GO:0016079) | 4.18461298 |
| 21 | * pyruvate metabolic process (GO:0006090) | 4.17499493 |
| 22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.12623955 |
| 23 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.12070605 |
| 24 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.09651668 |
| 25 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.07989010 |
| 26 | negative regulation of ligase activity (GO:0051352) | 4.07989010 |
| 27 | sodium ion export (GO:0071436) | 4.06019704 |
| 28 | cell communication by electrical coupling (GO:0010644) | 4.05015889 |
| 29 | respiratory electron transport chain (GO:0022904) | 4.04570463 |
| 30 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.03748928 |
| 31 | muscle filament sliding (GO:0030049) | 4.01141573 |
| 32 | actin-myosin filament sliding (GO:0033275) | 4.01141573 |
| 33 | protein deneddylation (GO:0000338) | 3.97213414 |
| 34 | establishment of viral latency (GO:0019043) | 3.96019591 |
| 35 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.95129436 |
| 36 | electron transport chain (GO:0022900) | 3.94916309 |
| 37 | * hexose biosynthetic process (GO:0019319) | 3.92939913 |
| 38 | succinate metabolic process (GO:0006105) | 3.92211142 |
| 39 | positive regulation of synapse maturation (GO:0090129) | 3.90893522 |
| 40 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.89166681 |
| 41 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.80120762 |
| 42 | ATP biosynthetic process (GO:0006754) | 3.79486256 |
| 43 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.79418278 |
| 44 | cardiac muscle contraction (GO:0060048) | 3.77076451 |
| 45 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.75886800 |
| 46 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.75886800 |
| 47 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.75886800 |
| 48 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.74561919 |
| 49 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.74561919 |
| 50 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.74217376 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 3.72709985 |
| 52 | sarcomere organization (GO:0045214) | 3.70832012 |
| 53 | DNA strand elongation (GO:0022616) | 3.70524500 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.65755958 |
| 55 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.64552102 |
| 56 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.64552102 |
| 57 | * monosaccharide biosynthetic process (GO:0046364) | 3.63408205 |
| 58 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.61104896 |
| 59 | regulation of mitochondrial translation (GO:0070129) | 3.59587037 |
| 60 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.57071455 |
| 61 | cardiac myofibril assembly (GO:0055003) | 3.55038014 |
| 62 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.53249420 |
| 63 | galactose catabolic process (GO:0019388) | 3.52943918 |
| 64 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.51691624 |
| 65 | L-serine metabolic process (GO:0006563) | 3.50438661 |
| 66 | DNA damage response, detection of DNA damage (GO:0042769) | 3.46235782 |
| 67 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.44720045 |
| 68 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.43611100 |
| 69 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.43611100 |
| 70 | tRNA aminoacylation for protein translation (GO:0006418) | 3.39999036 |
| 71 | positive regulation of ligase activity (GO:0051351) | 3.38642021 |
| 72 | chaperone-mediated protein transport (GO:0072321) | 3.37691080 |
| 73 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.37637588 |
| 74 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.37107472 |
| 75 | 4-hydroxyproline metabolic process (GO:0019471) | 3.35297261 |
| 76 | IMP biosynthetic process (GO:0006188) | 3.34606895 |
| 77 | amino acid activation (GO:0043038) | 3.34295574 |
| 78 | tRNA aminoacylation (GO:0043039) | 3.34295574 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 3.34245026 |
| 80 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.32302265 |
| 81 | purine nucleobase biosynthetic process (GO:0009113) | 3.31876885 |
| 82 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.30601099 |
| 83 | CENP-A containing nucleosome assembly (GO:0034080) | 3.27111330 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 3.25567911 |
| 85 | chromatin remodeling at centromere (GO:0031055) | 3.25376294 |
| 86 | lysine catabolic process (GO:0006554) | 3.24246481 |
| 87 | lysine metabolic process (GO:0006553) | 3.24246481 |
| 88 | ribosome assembly (GO:0042255) | 3.23222450 |
| 89 | spliceosomal snRNP assembly (GO:0000387) | 3.23029946 |
| 90 | striated muscle contraction (GO:0006941) | 3.17837403 |
| 91 | plasma membrane repair (GO:0001778) | 3.16682397 |
| 92 | DNA ligation (GO:0006266) | 3.16536118 |
| 93 | regulation of ligase activity (GO:0051340) | 3.16164401 |
| 94 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.14005079 |
| 95 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.14005079 |
| 96 | nucleobase biosynthetic process (GO:0046112) | 3.14002159 |
| 97 | mitotic metaphase plate congression (GO:0007080) | 3.13994322 |
| 98 | glutamate secretion (GO:0014047) | 3.13851319 |
| 99 | mitotic sister chromatid segregation (GO:0000070) | 3.11361590 |
| 100 | regulation of sulfur metabolic process (GO:0042762) | 3.09280045 |
| 101 | actin-mediated cell contraction (GO:0070252) | 3.08728613 |
| 102 | metaphase plate congression (GO:0051310) | 3.08579841 |
| 103 | telomere maintenance via recombination (GO:0000722) | 3.07804643 |
| 104 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.06687987 |
| 105 | protein targeting to mitochondrion (GO:0006626) | 3.05999533 |
| 106 | rRNA modification (GO:0000154) | 3.05445794 |
| 107 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.05302132 |
| 108 | cell communication involved in cardiac conduction (GO:0086065) | 3.04282446 |
| 109 | protein complex biogenesis (GO:0070271) | 3.04136026 |
| 110 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.03531865 |
| 111 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.01799829 |
| 112 | inner mitochondrial membrane organization (GO:0007007) | 3.01792014 |
| 113 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.01263926 |
| 114 | non-recombinational repair (GO:0000726) | 3.00527877 |
| 115 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.00527877 |
| 116 | mitotic recombination (GO:0006312) | 3.00316762 |
| 117 | DNA replication checkpoint (GO:0000076) | 2.99869437 |
| 118 | negative regulation of microtubule polymerization (GO:0031115) | 2.99719515 |
| 119 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.99532058 |
| 120 | termination of RNA polymerase III transcription (GO:0006386) | 2.99532058 |
| 121 | protein localization to kinetochore (GO:0034501) | 2.98770570 |
| 122 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.97323936 |
| 123 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.97323936 |
| 124 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.94917777 |
| 125 | respiratory chain complex IV assembly (GO:0008535) | 2.94404215 |
| 126 | regulation of cellular respiration (GO:0043457) | 2.94231995 |
| 127 | tricarboxylic acid metabolic process (GO:0072350) | 2.93945120 |
| 128 | synaptic vesicle maturation (GO:0016188) | 2.93395570 |
| 129 | aldehyde catabolic process (GO:0046185) | 2.93209285 |
| 130 | regulation of cellular amine metabolic process (GO:0033238) | 2.90790856 |
| 131 | regulation of skeletal muscle contraction (GO:0014819) | 2.90363560 |
| 132 | glycogen catabolic process (GO:0005980) | 2.90359251 |
| 133 | lactate metabolic process (GO:0006089) | 2.90233731 |
| 134 | protein localization to mitochondrion (GO:0070585) | 2.89974597 |
| 135 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.89797783 |
| 136 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.89205260 |
| 137 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.89117453 |
| 138 | DNA double-strand break processing (GO:0000729) | 2.88486003 |
| 139 | protein hydroxylation (GO:0018126) | 2.88482862 |
| 140 | myofibril assembly (GO:0030239) | 2.88316632 |
| 141 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.87426445 |
| 142 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.86386270 |
| 143 | establishment of protein localization to mitochondrion (GO:0072655) | 2.86161132 |
| 144 | vocalization behavior (GO:0071625) | 2.85869683 |
| 145 | neurotransmitter secretion (GO:0007269) | 2.84253084 |
| 146 | negative regulation of protein ubiquitination (GO:0031397) | 2.83276248 |
| 147 | cell cycle G1/S phase transition (GO:0044843) | 2.83248432 |
| 148 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.83248432 |
| 149 | 7-methylguanosine mRNA capping (GO:0006370) | 2.82184498 |
| 150 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.81039237 |
| 151 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80979453 |
| 152 | regulation of synapse structural plasticity (GO:0051823) | 2.80139329 |
| 153 | IMP metabolic process (GO:0046040) | 2.79984708 |
| 154 | protein localization to synapse (GO:0035418) | 2.79293649 |
| 155 | peptidyl-histidine modification (GO:0018202) | 2.79278606 |
| 156 | positive regulation of cell cycle arrest (GO:0071158) | 2.78705836 |
| 157 | NADH dehydrogenase complex assembly (GO:0010257) | 2.77235213 |
| 158 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.77235213 |
| 159 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.77235213 |
| 160 | formation of translation preinitiation complex (GO:0001731) | 2.77198049 |
| 161 | regulation of cell communication by electrical coupling (GO:0010649) | 2.76123863 |
| 162 | protein K6-linked ubiquitination (GO:0085020) | 2.74853350 |
| 163 | hydrogen ion transmembrane transport (GO:1902600) | 2.74647522 |
| 164 | glucan catabolic process (GO:0009251) | 2.74308755 |
| 165 | sister chromatid segregation (GO:0000819) | 2.73556318 |
| 166 | RNA capping (GO:0036260) | 2.73237303 |
| 167 | 7-methylguanosine RNA capping (GO:0009452) | 2.73237303 |
| 168 | histone exchange (GO:0043486) | 2.72045367 |
| 169 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.71184469 |
| 170 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.71184469 |
| 171 | ketone body metabolic process (GO:1902224) | 2.71081127 |
| 172 | peptidyl-proline hydroxylation (GO:0019511) | 2.70937218 |
| 173 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.70004247 |
| 174 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.69726209 |
| 175 | * glucose metabolic process (GO:0006006) | 2.68582548 |
| 176 | striatum development (GO:0021756) | 2.68437362 |
| 177 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.66013231 |
| 178 | cellular sodium ion homeostasis (GO:0006883) | 2.63184565 |
| 179 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.63101133 |
| 180 | muscle cell cellular homeostasis (GO:0046716) | 2.61465544 |
| 181 | regulation of membrane repolarization (GO:0060306) | 2.60833741 |
| 182 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.60829262 |
| 183 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.60829262 |
| 184 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.60584708 |
| 185 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.60584708 |
| 186 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.58453515 |
| 187 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.57891355 |
| 188 | cellular polysaccharide catabolic process (GO:0044247) | 2.57112774 |
| 189 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.56388106 |
| 190 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.55627772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.82285430 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.25694293 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.00509983 |
| 4 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.69175921 |
| 5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.21616618 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.14616366 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.94778507 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.35973823 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.26057582 |
| 10 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.88677125 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.84572788 |
| 12 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.79447392 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.78568204 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.68995388 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.53315302 |
| 16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.51097783 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35582330 |
| 18 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.34729781 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23825094 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.22550670 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21055203 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20406316 |
| 23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17676197 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.15864055 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.12540253 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.11082838 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.06867944 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.06644794 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.05931095 |
| 30 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.04434678 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.02573234 |
| 32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.02335865 |
| 33 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.97317915 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.95790884 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.94842812 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.94394746 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90018800 |
| 38 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87148053 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.86465137 |
| 40 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.85654780 |
| 41 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84113030 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.81682587 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.80970409 |
| 44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77973758 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.77220228 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.76801704 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.73324559 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72553602 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.72292845 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72075453 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.70799039 |
| 52 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69474178 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.67535338 |
| 54 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67205520 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65140452 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63349018 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59120735 |
| 58 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58763075 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.58223831 |
| 60 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.56491649 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.53434909 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51500589 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.49627200 |
| 64 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.47830321 |
| 65 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47549376 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47178310 |
| 67 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46542238 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45591611 |
| 69 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42854360 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.42056653 |
| 71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.40726393 |
| 72 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.38545901 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38468673 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36356663 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36186965 |
| 76 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35370315 |
| 77 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35370315 |
| 78 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.34688972 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33620026 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32745951 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31437755 |
| 82 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28369474 |
| 83 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28217100 |
| 84 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.26741858 |
| 85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25106444 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24358543 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24162672 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.21894501 |
| 89 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21196412 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20830408 |
| 91 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19917325 |
| 92 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.19532751 |
| 93 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18380666 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18214452 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.17461844 |
| 96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17136083 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17123769 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16844426 |
| 99 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15601025 |
| 100 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15396489 |
| 101 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.15028090 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13799708 |
| 103 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13638460 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12286951 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11987930 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11932710 |
| 107 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11778531 |
| 108 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11656068 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11412550 |
| 110 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.11308345 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10848415 |
| 112 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.10141623 |
| 113 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09993418 |
| 114 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.09352241 |
| 115 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09259675 |
| 116 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08912539 |
| 117 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07694783 |
| 118 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07477261 |
| 119 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06612327 |
| 120 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06218543 |
| 121 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06006353 |
| 122 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05868260 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05747584 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.05738950 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05290575 |
| 126 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.04190159 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04016468 |
| 128 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.03842702 |
| 129 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03135994 |
| 130 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02661963 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01791075 |
| 132 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01301637 |
| 133 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.01230553 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01180992 |
| 135 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00865507 |
| 136 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00533239 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98666081 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98181811 |
| 139 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.97895491 |
| 140 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97743400 |
| 141 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97002820 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96865571 |
| 143 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96506453 |
| 144 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95711883 |
| 145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94994510 |
| 146 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94812783 |
| 147 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.94541799 |
| 148 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92967582 |
| 149 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92694789 |
| 150 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91824225 |
| 151 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91085132 |
| 152 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90319324 |
| 153 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.90045613 |
| 154 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.87446629 |
| 155 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85568006 |
| 156 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.83631455 |
| 157 | EWS_26573619_Chip-Seq_HEK293_Human | 0.81375045 |
| 158 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80368039 |
| 159 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78269155 |
| 160 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77604194 |
| 161 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.76487831 |
| 162 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.75182312 |
| 163 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72404275 |
| 164 | FUS_26573619_Chip-Seq_HEK293_Human | 0.70748118 |
| 165 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.70287779 |
| 166 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.69923029 |
| 167 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.68800430 |
| 168 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67946363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.61879373 |
| 2 | MP0000751_myopathy | 3.94181711 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.81145036 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.79672555 |
| 5 | MP0008058_abnormal_DNA_repair | 3.77187293 |
| 6 | MP0003646_muscle_fatigue | 3.51241738 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.25060917 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.20626066 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.03882094 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.95957276 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.94026019 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.93061303 |
| 13 | MP0004233_abnormal_muscle_weight | 2.91505557 |
| 14 | MP0000749_muscle_degeneration | 2.83609521 |
| 15 | MP0003077_abnormal_cell_cycle | 2.79130124 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.75098379 |
| 17 | MP0002938_white_spotting | 2.43982805 |
| 18 | MP0004145_abnormal_muscle_electrophysio | 2.41823950 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.15410731 |
| 20 | MP0005330_cardiomyopathy | 2.11820438 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.08394164 |
| 22 | MP0002269_muscular_atrophy | 2.07562508 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.05260906 |
| 24 | MP0000747_muscle_weakness | 2.04663845 |
| 25 | MP0003786_premature_aging | 2.03734959 |
| 26 | MP0008775_abnormal_heart_ventricle | 2.03235960 |
| 27 | MP0003880_abnormal_central_pattern | 2.00869818 |
| 28 | MP0003718_maternal_effect | 1.99885930 |
| 29 | MP0003186_abnormal_redox_activity | 1.99823550 |
| 30 | MP0004087_abnormal_muscle_fiber | 1.96217847 |
| 31 | MP0002822_catalepsy | 1.93538859 |
| 32 | MP0003136_yellow_coat_color | 1.89336971 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.84083230 |
| 34 | MP0002972_abnormal_cardiac_muscle | 1.80537040 |
| 35 | MP0008789_abnormal_olfactory_epithelium | 1.78589789 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.78224178 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.77531178 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.77338343 |
| 39 | MP0006292_abnormal_olfactory_placode | 1.76798603 |
| 40 | MP0009697_abnormal_copulation | 1.75971341 |
| 41 | MP0002090_abnormal_vision | 1.73280768 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.72311213 |
| 43 | MP0005499_abnormal_olfactory_system | 1.70407450 |
| 44 | MP0005394_taste/olfaction_phenotype | 1.70407450 |
| 45 | MP0004484_altered_response_of | 1.65640016 |
| 46 | MP0002064_seizures | 1.65174622 |
| 47 | MP0009745_abnormal_behavioral_response | 1.64981333 |
| 48 | MP0003122_maternal_imprinting | 1.64077729 |
| 49 | MP0004147_increased_porphyrin_level | 1.63807632 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.63323262 |
| 51 | MP0009046_muscle_twitch | 1.63231784 |
| 52 | MP0000759_abnormal_skeletal_muscle | 1.63071149 |
| 53 | MP0001293_anophthalmia | 1.62533019 |
| 54 | MP0002102_abnormal_ear_morphology | 1.61992937 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.61663736 |
| 56 | MP0004130_abnormal_muscle_cell | 1.61642069 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59593033 |
| 58 | MP0005171_absent_coat_pigmentation | 1.58871859 |
| 59 | MP0002736_abnormal_nociception_after | 1.58035943 |
| 60 | MP0006035_abnormal_mitochondrial_morpho | 1.56911365 |
| 61 | MP0003123_paternal_imprinting | 1.56112670 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.54597905 |
| 63 | MP0002063_abnormal_learning/memory/cond | 1.54297528 |
| 64 | MP0003137_abnormal_impulse_conducting | 1.51045988 |
| 65 | MP0003329_amyloid_beta_deposits | 1.50820095 |
| 66 | MP0001529_abnormal_vocalization | 1.47909466 |
| 67 | MP0005369_muscle_phenotype | 1.42327171 |
| 68 | MP0005385_cardiovascular_system_phenoty | 1.36651228 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 1.36651228 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.36000061 |
| 71 | MP0004858_abnormal_nervous_system | 1.35446034 |
| 72 | MP0004085_abnormal_heartbeat | 1.34575407 |
| 73 | MP0005360_urolithiasis | 1.33317455 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.27842533 |
| 75 | MP0006138_congestive_heart_failure | 1.27733133 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.26841769 |
| 77 | MP0005408_hypopigmentation | 1.23553350 |
| 78 | MP0003937_abnormal_limbs/digits/tail_de | 1.23290308 |
| 79 | MP0002272_abnormal_nervous_system | 1.19352997 |
| 80 | MP0002233_abnormal_nose_morphology | 1.18774383 |
| 81 | MP0001346_abnormal_lacrimal_gland | 1.18254668 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 1.17958723 |
| 83 | MP0004043_abnormal_pH_regulation | 1.14180380 |
| 84 | MP0001764_abnormal_homeostasis | 1.12758178 |
| 85 | MP0010630_abnormal_cardiac_muscle | 1.12069511 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 1.08551805 |
| 87 | MP0002572_abnormal_emotion/affect_behav | 1.07787584 |
| 88 | MP0001697_abnormal_embryo_size | 1.07733735 |
| 89 | MP0006072_abnormal_retinal_apoptosis | 1.07635640 |
| 90 | MP0001730_embryonic_growth_arrest | 1.06290823 |
| 91 | MP0000647_abnormal_sebaceous_gland | 1.05557729 |
| 92 | MP0004924_abnormal_behavior | 1.05356612 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.05356612 |
| 94 | MP0002751_abnormal_autonomic_nervous | 1.04524361 |
| 95 | MP0000350_abnormal_cell_proliferation | 1.04142695 |
| 96 | MP0005266_abnormal_metabolism | 1.02693791 |
| 97 | MP0002067_abnormal_sensory_capabilities | 1.02234511 |
| 98 | MP0001440_abnormal_grooming_behavior | 1.02230834 |
| 99 | MP0001984_abnormal_olfaction | 1.02221884 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 1.01139662 |
| 101 | MP0000013_abnormal_adipose_tissue | 1.00773682 |
| 102 | MP0004270_analgesia | 0.99953400 |
| 103 | MP0000566_synostosis | 0.98655526 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.98065070 |
| 105 | MP0002210_abnormal_sex_determination | 0.97832311 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.97736168 |
| 107 | MP0008872_abnormal_physiological_respon | 0.97690970 |
| 108 | MP0003121_genomic_imprinting | 0.96045138 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.95910188 |
| 110 | MP0003941_abnormal_skin_development | 0.95310309 |
| 111 | MP0002697_abnormal_eye_size | 0.91324899 |
| 112 | MP0003315_abnormal_perineum_morphology | 0.90875545 |
| 113 | MP0004133_heterotaxia | 0.90821386 |
| 114 | MP0001672_abnormal_embryogenesis/_devel | 0.90778613 |
| 115 | MP0005380_embryogenesis_phenotype | 0.90778613 |
| 116 | * MP0002080_prenatal_lethality | 0.90335001 |
| 117 | MP0003283_abnormal_digestive_organ | 0.89504592 |
| 118 | MP0001286_abnormal_eye_development | 0.89256429 |
| 119 | MP0002282_abnormal_trachea_morphology | 0.87855126 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.86955934 |
| 121 | MP0003806_abnormal_nucleotide_metabolis | 0.86705395 |
| 122 | MP0004811_abnormal_neuron_physiology | 0.86147695 |
| 123 | MP0002163_abnormal_gland_morphology | 0.86120923 |
| 124 | MP0001929_abnormal_gametogenesis | 0.84867413 |
| 125 | MP0002735_abnormal_chemical_nociception | 0.84638095 |
| 126 | MP0002084_abnormal_developmental_patter | 0.84200190 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.83245233 |
| 128 | MP0000579_abnormal_nail_morphology | 0.82409236 |
| 129 | MP0002184_abnormal_innervation | 0.82000981 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.81484515 |
| 131 | MP0003755_abnormal_palate_morphology | 0.80522488 |
| 132 | MP0010030_abnormal_orbit_morphology | 0.79760941 |
| 133 | MP0000537_abnormal_urethra_morphology | 0.79392277 |
| 134 | MP0002127_abnormal_cardiovascular_syste | 0.79128625 |
| 135 | MP0005391_vision/eye_phenotype | 0.78919870 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.78839221 |
| 137 | MP0008569_lethality_at_weaning | 0.78738773 |
| 138 | MP0008057_abnormal_DNA_replication | 0.78223914 |
| 139 | MP0000653_abnormal_sex_gland | 0.77729235 |
| 140 | MP0008995_early_reproductive_senescence | 0.77247026 |
| 141 | MP0000358_abnormal_cell_content/ | 0.76441598 |
| 142 | MP0004272_abnormal_basement_membrane | 0.75712453 |
| 143 | MP0005332_abnormal_amino_acid | 0.75516157 |
| 144 | MP0001324_abnormal_eye_pigmentation | 0.74994242 |
| 145 | MP0004142_abnormal_muscle_tone | 0.74944858 |
| 146 | MP0009672_abnormal_birth_weight | 0.74644774 |
| 147 | MP0001145_abnormal_male_reproductive | 0.74211851 |
| 148 | MP0000313_abnormal_cell_death | 0.73944645 |
| 149 | MP0005253_abnormal_eye_physiology | 0.72434681 |
| 150 | MP0000049_abnormal_middle_ear | 0.72350071 |
| 151 | MP0002066_abnormal_motor_capabilities/c | 0.72223333 |
| 152 | MP0003984_embryonic_growth_retardation | 0.71754921 |
| 153 | MP0003938_abnormal_ear_development | 0.71515905 |
| 154 | MP0005187_abnormal_penis_morphology | 0.71357942 |
| 155 | MP0003879_abnormal_hair_cell | 0.69767056 |
| 156 | MP0002088_abnormal_embryonic_growth/wei | 0.69557921 |
| 157 | MP0010329_abnormal_lipoprotein_level | 0.69088297 |
| 158 | MP0002111_abnormal_tail_morphology | 0.68679664 |
| 159 | MP0005670_abnormal_white_adipose | 0.66916381 |
| 160 | MP0005367_renal/urinary_system_phenotyp | 0.66901541 |
| 161 | MP0000516_abnormal_urinary_system | 0.66901541 |
| 162 | MP0000230_abnormal_systemic_arterial | 0.66608893 |
| 163 | MP0005666_abnormal_adipose_tissue | 0.65861178 |
| 164 | MP0002139_abnormal_hepatobiliary_system | 0.65736859 |
| 165 | MP0001727_abnormal_embryo_implantation | 0.65577280 |
| 166 | MP0003011_delayed_dark_adaptation | 0.64461715 |
| 167 | MP0005535_abnormal_body_temperature | 0.64023693 |
| 168 | MP0006276_abnormal_autonomic_nervous | 0.63129882 |
| 169 | MP0001970_abnormal_pain_threshold | 0.62511517 |
| 170 | MP0001502_abnormal_circadian_rhythm | 0.61214494 |
| 171 | MP0000604_amyloidosis | 0.60552902 |
| 172 | MP0008961_abnormal_basal_metabolism | 0.59897216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 6.63174559 |
| 2 | Myoglobinuria (HP:0002913) | 5.36458424 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.77382574 |
| 4 | Abnormality of glycolysis (HP:0004366) | 4.22925132 |
| 5 | Increased serum pyruvate (HP:0003542) | 4.22925132 |
| 6 | Rhabdomyolysis (HP:0003201) | 4.22897109 |
| 7 | Sudden death (HP:0001699) | 4.13372342 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.86522100 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.59085807 |
| 10 | Central scotoma (HP:0000603) | 3.51138892 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 3.50681578 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.44623021 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.39388262 |
| 14 | Muscle stiffness (HP:0003552) | 3.35862986 |
| 15 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.29286420 |
| 16 | Abnormality of the labia minora (HP:0012880) | 3.25450240 |
| 17 | Visual hallucinations (HP:0002367) | 3.24894429 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 3.21522306 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20701337 |
| 20 | Mitochondrial inheritance (HP:0001427) | 3.18722022 |
| 21 | Acute encephalopathy (HP:0006846) | 3.15380248 |
| 22 | Hepatocellular necrosis (HP:0001404) | 3.14391831 |
| 23 | Ragged-red muscle fibers (HP:0003200) | 3.10322700 |
| 24 | Palpitations (HP:0001962) | 3.09448909 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 3.06058410 |
| 26 | Meckel diverticulum (HP:0002245) | 3.05022731 |
| 27 | Increased CSF lactate (HP:0002490) | 3.02010020 |
| 28 | Pheochromocytoma (HP:0002666) | 3.00737925 |
| 29 | Exercise intolerance (HP:0003546) | 2.95099527 |
| 30 | Progressive macrocephaly (HP:0004481) | 2.95079993 |
| 31 | Chromsome breakage (HP:0040012) | 2.93144600 |
| 32 | Abnormality of the ileum (HP:0001549) | 2.91980196 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.91158806 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 2.88640389 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.87680125 |
| 36 | Degeneration of anterior horn cells (HP:0002398) | 2.87680125 |
| 37 | Colon cancer (HP:0003003) | 2.85048901 |
| 38 | Focal motor seizures (HP:0011153) | 2.84872856 |
| 39 | Myokymia (HP:0002411) | 2.84856065 |
| 40 | Hepatic necrosis (HP:0002605) | 2.84059866 |
| 41 | Myotonia (HP:0002486) | 2.74239165 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.73867952 |
| 43 | Microvesicular hepatic steatosis (HP:0001414) | 2.68356646 |
| 44 | Type I transferrin isoform profile (HP:0003642) | 2.65531820 |
| 45 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.64635271 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.63517347 |
| 47 | Asymmetric septal hypertrophy (HP:0001670) | 2.62548833 |
| 48 | Cerebral edema (HP:0002181) | 2.61108802 |
| 49 | Conjunctival hamartoma (HP:0100780) | 2.60805190 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.59527384 |
| 51 | Abnormality of the preputium (HP:0100587) | 2.58306536 |
| 52 | Emotional lability (HP:0000712) | 2.53579141 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.53033476 |
| 54 | Ependymoma (HP:0002888) | 2.50415972 |
| 55 | Lactic acidosis (HP:0003128) | 2.47621706 |
| 56 | Muscle fiber inclusion bodies (HP:0100299) | 2.46747001 |
| 57 | Absence seizures (HP:0002121) | 2.43532023 |
| 58 | Reticulocytopenia (HP:0001896) | 2.41724159 |
| 59 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.39534664 |
| 60 | Increased connective tissue (HP:0009025) | 2.38884542 |
| 61 | Atrial fibrillation (HP:0005110) | 2.37995105 |
| 62 | Hyperglycinemia (HP:0002154) | 2.35556380 |
| 63 | Angiofibromas (HP:0010615) | 2.34794793 |
| 64 | Adenoma sebaceum (HP:0009720) | 2.34794793 |
| 65 | Limb-girdle muscle atrophy (HP:0003797) | 2.34514699 |
| 66 | Ventricular fibrillation (HP:0001663) | 2.33357489 |
| 67 | Dysmetric saccades (HP:0000641) | 2.33194091 |
| 68 | Supraventricular tachycardia (HP:0004755) | 2.33134900 |
| 69 | Ventricular tachycardia (HP:0004756) | 2.32403378 |
| 70 | Abnormality of methionine metabolism (HP:0010901) | 2.31401083 |
| 71 | Hypoplastic pelvis (HP:0008839) | 2.30920549 |
| 72 | Primary atrial arrhythmia (HP:0001692) | 2.30825387 |
| 73 | Scotoma (HP:0000575) | 2.30178667 |
| 74 | Supraventricular arrhythmia (HP:0005115) | 2.29070440 |
| 75 | Lipoatrophy (HP:0100578) | 2.28761685 |
| 76 | Difficulty climbing stairs (HP:0003551) | 2.25361560 |
| 77 | Postnatal microcephaly (HP:0005484) | 2.24017177 |
| 78 | Syncope (HP:0001279) | 2.23894660 |
| 79 | Ketoacidosis (HP:0001993) | 2.23031704 |
| 80 | Abnormality of chromosome stability (HP:0003220) | 2.22806919 |
| 81 | Ventricular arrhythmia (HP:0004308) | 2.22629713 |
| 82 | Respiratory failure (HP:0002878) | 2.22607525 |
| 83 | Gout (HP:0001997) | 2.21175681 |
| 84 | * Abnormal gallbladder physiology (HP:0012438) | 2.20814072 |
| 85 | * Cholecystitis (HP:0001082) | 2.20814072 |
| 86 | Muscle fiber splitting (HP:0003555) | 2.18692440 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17311241 |
| 88 | Shoulder girdle muscle weakness (HP:0003547) | 2.16999212 |
| 89 | Cerebral hypomyelination (HP:0006808) | 2.16671905 |
| 90 | Abnormal lung lobation (HP:0002101) | 2.16515606 |
| 91 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.14527881 |
| 92 | Prolonged QT interval (HP:0001657) | 2.12886005 |
| 93 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12856095 |
| 94 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12856095 |
| 95 | Abnormal protein glycosylation (HP:0012346) | 2.12856095 |
| 96 | Abnormal glycosylation (HP:0012345) | 2.12856095 |
| 97 | Resting tremor (HP:0002322) | 2.11287870 |
| 98 | Hamartoma of the eye (HP:0010568) | 2.11031206 |
| 99 | Myopathic facies (HP:0002058) | 2.10822268 |
| 100 | Methylmalonic aciduria (HP:0012120) | 2.10636852 |
| 101 | Leukodystrophy (HP:0002415) | 2.10113594 |
| 102 | Hyporeflexia of lower limbs (HP:0002600) | 2.09438283 |
| 103 | Difficulty running (HP:0009046) | 2.09089549 |
| 104 | Increased serum lactate (HP:0002151) | 2.08566170 |
| 105 | Neoplasm of the adrenal gland (HP:0100631) | 2.06632174 |
| 106 | Abnormality of the lower motor neuron (HP:0002366) | 2.05903105 |
| 107 | Rimmed vacuoles (HP:0003805) | 2.05569934 |
| 108 | Duodenal stenosis (HP:0100867) | 2.05459665 |
| 109 | Small intestinal stenosis (HP:0012848) | 2.05459665 |
| 110 | Distal arthrogryposis (HP:0005684) | 2.04950381 |
| 111 | Athetosis (HP:0002305) | 2.04266229 |
| 112 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04081135 |
| 113 | Epileptic encephalopathy (HP:0200134) | 2.04071395 |
| 114 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03934755 |
| 115 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03571652 |
| 116 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03571652 |
| 117 | Subaortic stenosis (HP:0001682) | 2.02571337 |
| 118 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.02571337 |
| 119 | Reticulocytosis (HP:0001923) | 2.02163188 |
| 120 | Right ventricular cardiomyopathy (HP:0011663) | 2.01831726 |
| 121 | Horseshoe kidney (HP:0000085) | 2.01694272 |
| 122 | True hermaphroditism (HP:0010459) | 1.99474635 |
| 123 | Nemaline bodies (HP:0003798) | 1.99167814 |
| 124 | Methylmalonic acidemia (HP:0002912) | 1.98506782 |
| 125 | Lethargy (HP:0001254) | 1.97753637 |
| 126 | CNS demyelination (HP:0007305) | 1.97665042 |
| 127 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.96467660 |
| 128 | Bifid tongue (HP:0010297) | 1.96266337 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94969769 |
| 130 | Abnormality of alanine metabolism (HP:0010916) | 1.94969769 |
| 131 | Hyperalaninemia (HP:0003348) | 1.94969769 |
| 132 | Focal seizures (HP:0007359) | 1.93780973 |
| 133 | Round ear (HP:0100830) | 1.93406322 |
| 134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92999400 |
| 135 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92912040 |
| 136 | Achilles tendon contracture (HP:0001771) | 1.91471228 |
| 137 | Dialeptic seizures (HP:0011146) | 1.90921920 |
| 138 | Atonic seizures (HP:0010819) | 1.90543311 |
| 139 | Depression (HP:0000716) | 1.90371003 |
| 140 | Generalized tonic-clonic seizures (HP:0002069) | 1.90172651 |
| 141 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.89428157 |
| 142 | Ketosis (HP:0001946) | 1.89328434 |
| 143 | Abnormality of glycine metabolism (HP:0010895) | 1.88593150 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88593150 |
| 145 | Abnormality of serum amino acid levels (HP:0003112) | 1.87814709 |
| 146 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.85438174 |
| 147 | Pancreatic fibrosis (HP:0100732) | 1.85107043 |
| 148 | * Optic disc pallor (HP:0000543) | 1.84029869 |
| 149 | Abnormality of the duodenum (HP:0002246) | 1.83746513 |
| 150 | X-linked dominant inheritance (HP:0001423) | 1.81323595 |
| 151 | Pancreatic cysts (HP:0001737) | 1.80954838 |
| 152 | Hyperglycinuria (HP:0003108) | 1.78110054 |
| 153 | Poor suck (HP:0002033) | 1.77677009 |
| 154 | Preaxial hand polydactyly (HP:0001177) | 1.77516791 |
| 155 | CNS hypomyelination (HP:0003429) | 1.77441563 |
| 156 | Absent radius (HP:0003974) | 1.76441164 |
| 157 | Abnormality of placental membranes (HP:0011409) | 1.74971356 |
| 158 | Amniotic constriction ring (HP:0009775) | 1.74971356 |
| 159 | Sclerocornea (HP:0000647) | 1.74780372 |
| 160 | Respiratory difficulties (HP:0002880) | 1.74687128 |
| 161 | Reduced antithrombin III activity (HP:0001976) | 1.73164331 |
| 162 | Sloping forehead (HP:0000340) | 1.72641363 |
| 163 | Birth length less than 3rd percentile (HP:0003561) | 1.72415135 |
| 164 | Pancytopenia (HP:0001876) | 1.71920621 |
| 165 | Astrocytoma (HP:0009592) | 1.70643052 |
| 166 | Abnormality of the astrocytes (HP:0100707) | 1.70643052 |
| 167 | Triphalangeal thumb (HP:0001199) | 1.69503070 |
| 168 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.69424076 |
| 169 | Absent forearm bone (HP:0003953) | 1.68873626 |
| 170 | Aplasia involving forearm bones (HP:0009822) | 1.68873626 |
| 171 | Abnormality of the carotid arteries (HP:0005344) | 1.66972055 |
| 172 | Secondary amenorrhea (HP:0000869) | 1.66016497 |
| 173 | Cortical dysplasia (HP:0002539) | 1.64799032 |
| 174 | Medial flaring of the eyebrow (HP:0010747) | 1.62886110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 4.77023913 |
| 2 | PKN2 | 4.33243579 |
| 3 | VRK2 | 4.01562489 |
| 4 | PBK | 3.08470684 |
| 5 | NME1 | 2.98431958 |
| 6 | SRPK1 | 2.87047937 |
| 7 | TRIM28 | 2.84930483 |
| 8 | EIF2AK1 | 2.65145884 |
| 9 | TRIB3 | 2.63387895 |
| 10 | OBSCN | 2.57178967 |
| 11 | TTN | 2.51587123 |
| 12 | MAP3K9 | 2.41619065 |
| 13 | CDC7 | 2.31359113 |
| 14 | STK16 | 2.24781253 |
| 15 | KSR2 | 2.18638640 |
| 16 | TTK | 2.16567774 |
| 17 | MAP3K4 | 2.16074095 |
| 18 | PLK3 | 2.14550424 |
| 19 | PDK3 | 2.13833887 |
| 20 | PDK4 | 2.13833887 |
| 21 | PHKG2 | 2.13702437 |
| 22 | PHKG1 | 2.13702437 |
| 23 | EIF2AK3 | 2.10315959 |
| 24 | ZAK | 2.06091911 |
| 25 | MST4 | 2.06055530 |
| 26 | VRK1 | 2.05798360 |
| 27 | MINK1 | 1.98570787 |
| 28 | BCKDK | 1.94302456 |
| 29 | MAP3K12 | 1.93911085 |
| 30 | LMTK2 | 1.90108309 |
| 31 | ARAF | 1.81279096 |
| 32 | NTRK3 | 1.80540392 |
| 33 | EPHA4 | 1.76239999 |
| 34 | MAP2K4 | 1.75636647 |
| 35 | PAK6 | 1.71909902 |
| 36 | NME2 | 1.66417340 |
| 37 | MYLK | 1.59036636 |
| 38 | KSR1 | 1.58105010 |
| 39 | PLK4 | 1.57681561 |
| 40 | MAP4K2 | 1.52030184 |
| 41 | NUAK1 | 1.48870763 |
| 42 | BCR | 1.43246159 |
| 43 | BRSK2 | 1.40811859 |
| 44 | SCYL2 | 1.40715353 |
| 45 | PLK1 | 1.38191591 |
| 46 | MST1R | 1.36962833 |
| 47 | FLT3 | 1.32209370 |
| 48 | DAPK1 | 1.31949705 |
| 49 | MKNK1 | 1.30527354 |
| 50 | RIPK1 | 1.23615568 |
| 51 | DAPK3 | 1.23313259 |
| 52 | CDK19 | 1.21290839 |
| 53 | CSNK1G3 | 1.18160845 |
| 54 | TAF1 | 1.16322579 |
| 55 | BMPR1B | 1.14582926 |
| 56 | EEF2K | 1.12545137 |
| 57 | DAPK2 | 1.11639034 |
| 58 | MKNK2 | 1.11105201 |
| 59 | CAMKK1 | 1.09890376 |
| 60 | PLK2 | 1.06202985 |
| 61 | PTK2B | 1.05901586 |
| 62 | TAOK2 | 1.04816081 |
| 63 | CSNK1G1 | 1.04695218 |
| 64 | LATS2 | 0.99374478 |
| 65 | ILK | 0.97043515 |
| 66 | SIK3 | 0.96065481 |
| 67 | STK38 | 0.95320781 |
| 68 | CSNK1A1L | 0.93988968 |
| 69 | TSSK6 | 0.93896438 |
| 70 | MAP3K11 | 0.92743817 |
| 71 | CSNK1G2 | 0.91937782 |
| 72 | MAP3K7 | 0.91561637 |
| 73 | AURKB | 0.90559752 |
| 74 | ATR | 0.90439931 |
| 75 | DYRK2 | 0.88972894 |
| 76 | PAK4 | 0.86250358 |
| 77 | RAF1 | 0.84027583 |
| 78 | TESK1 | 0.83641449 |
| 79 | CHEK2 | 0.83603206 |
| 80 | CDK14 | 0.83053883 |
| 81 | CDK15 | 0.82807922 |
| 82 | CDK18 | 0.82310616 |
| 83 | MAP2K7 | 0.81622888 |
| 84 | TNIK | 0.80835591 |
| 85 | ERBB4 | 0.78096859 |
| 86 | CDK8 | 0.77770391 |
| 87 | CASK | 0.77092030 |
| 88 | FGFR1 | 0.76553752 |
| 89 | ERBB3 | 0.75750750 |
| 90 | FER | 0.75459400 |
| 91 | MAP2K3 | 0.73224892 |
| 92 | WEE1 | 0.73149157 |
| 93 | BMX | 0.72752890 |
| 94 | EIF2AK2 | 0.72410753 |
| 95 | MAP2K1 | 0.72081005 |
| 96 | PDK2 | 0.72080597 |
| 97 | CDK11A | 0.71741905 |
| 98 | AKT2 | 0.70272905 |
| 99 | GRK6 | 0.70124449 |
| 100 | LIMK1 | 0.69761296 |
| 101 | WNK4 | 0.69102009 |
| 102 | CCNB1 | 0.69020519 |
| 103 | RET | 0.68840683 |
| 104 | STK38L | 0.68594930 |
| 105 | PRKCG | 0.68448972 |
| 106 | NTRK1 | 0.66707953 |
| 107 | AURKA | 0.66485368 |
| 108 | GRK5 | 0.66113826 |
| 109 | PAK3 | 0.64232284 |
| 110 | PINK1 | 0.60563032 |
| 111 | NEK2 | 0.59510786 |
| 112 | ROCK2 | 0.58881912 |
| 113 | CDK5 | 0.57996513 |
| 114 | CDK7 | 0.57906342 |
| 115 | CAMKK2 | 0.56811910 |
| 116 | BRAF | 0.56295144 |
| 117 | CAMK2A | 0.55316667 |
| 118 | CAMK2D | 0.53604755 |
| 119 | TLK1 | 0.52902762 |
| 120 | PIM2 | 0.52448254 |
| 121 | CHEK1 | 0.52418061 |
| 122 | BUB1 | 0.51934026 |
| 123 | MAP3K5 | 0.51334042 |
| 124 | ATM | 0.49691393 |
| 125 | BRSK1 | 0.49410371 |
| 126 | PRKD3 | 0.49276883 |
| 127 | CSNK2A1 | 0.49191565 |
| 128 | LRRK2 | 0.47830798 |
| 129 | CAMK1 | 0.47180612 |
| 130 | PRKCI | 0.47112333 |
| 131 | MOS | 0.47092685 |
| 132 | PASK | 0.45226412 |
| 133 | STK4 | 0.45030880 |
| 134 | CSNK2A2 | 0.44921980 |
| 135 | MAP3K13 | 0.44706796 |
| 136 | EPHA2 | 0.43253358 |
| 137 | MAP2K6 | 0.43095314 |
| 138 | ROCK1 | 0.39740474 |
| 139 | STK39 | 0.38712462 |
| 140 | RPS6KB2 | 0.38546505 |
| 141 | INSRR | 0.38096501 |
| 142 | RPS6KA4 | 0.37300203 |
| 143 | WNK3 | 0.36848741 |
| 144 | MAPK12 | 0.35999137 |
| 145 | OXSR1 | 0.35360018 |
| 146 | MAPKAPK5 | 0.34729067 |
| 147 | MAP3K1 | 0.34572533 |
| 148 | EPHB2 | 0.33565254 |
| 149 | TAOK1 | 0.33394703 |
| 150 | ADRBK1 | 0.32164193 |
| 151 | TGFBR1 | 0.32057090 |
| 152 | PTK6 | 0.31932925 |
| 153 | ALK | 0.31549719 |
| 154 | PRKG2 | 0.31138066 |
| 155 | CDK1 | 0.30558432 |
| 156 | RPS6KA5 | 0.30312059 |
| 157 | MAPKAPK3 | 0.29964231 |
| 158 | PAK1 | 0.29456842 |
| 159 | MET | 0.27847002 |
| 160 | TESK2 | 0.27580270 |
| 161 | MAP3K8 | 0.27122737 |
| 162 | CAMK2G | 0.26746969 |
| 163 | RIPK4 | 0.25701711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.65213200 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.81213788 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19877537 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.04339271 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.03754408 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01330786 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.87849246 |
| 8 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.80664887 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.74627291 |
| 10 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.70538815 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.62383029 |
| 12 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.54515277 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.48256704 |
| 14 | Protein export_Homo sapiens_hsa03060 | 2.33487164 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.31222710 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 2.26550594 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.22082038 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 2.08410183 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.07609194 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 2.07339276 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.84341819 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.83936640 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77837567 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.76865358 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.76731959 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.74483165 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74092877 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72794234 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71047068 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.67762595 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.67584719 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66364532 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.65838917 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.64166159 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64031992 |
| 36 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.60675542 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.58952487 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.53084077 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50161731 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.45347358 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.42864663 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42521400 |
| 43 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37053829 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37022786 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 1.34120965 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33814496 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.33747929 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33740906 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33246210 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.27594550 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24886511 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21854941 |
| 53 | Cell cycle_Homo sapiens_hsa04110 | 1.21845381 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21501410 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21167973 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19570498 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 1.19156110 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.16977498 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16872304 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12927652 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.12116831 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11280407 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11082197 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.06680213 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 1.04236599 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01354796 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00901767 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99805425 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99083411 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.93799751 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92762303 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91954512 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90610113 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90531232 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90430144 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.90414041 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89484664 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89333649 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88867967 |
| 80 | Insulin secretion_Homo sapiens_hsa04911 | 0.87022280 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85942771 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85718157 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84093934 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83777775 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82806520 |
| 86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81616181 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79589900 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74008627 |
| 89 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72873334 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70127467 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.69701312 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.69567310 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.69076467 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67813023 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66460077 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65460675 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.63054316 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60756844 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.60383860 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59625161 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59307958 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59210506 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58984010 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58028214 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54364611 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53488669 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52991730 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50801162 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48006220 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47900970 |
| 111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47406544 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47251782 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44679829 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | 0.43922316 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.43860642 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43049400 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42501840 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41548585 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39927367 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39847136 |
| 121 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39262147 |
| 122 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39056550 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.38743020 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37382292 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36508859 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.35807806 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35240564 |
| 128 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.32933202 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31170808 |
| 130 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30754143 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30591772 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30431088 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.30019956 |
| 134 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29060800 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27823677 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27784883 |
| 137 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.26799231 |
| 138 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26651788 |
| 139 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26600666 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26457542 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25170470 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.25151489 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22419771 |
| 144 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.21910348 |
| 145 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.21809499 |
| 146 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21069436 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20627647 |
| 148 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19982656 |
| 149 | Lysine degradation_Homo sapiens_hsa00310 | 0.19121040 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | 0.18353283 |
| 151 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18023275 |
| 152 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.15584740 |
| 153 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.15355533 |
| 154 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.13342034 |

